TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,706,152 | +5.2% | 379,443 | +3.5% | 1.62% | -8.8% |
| Q1 2023 | $9,230,699 | +123.2% | 366,443 | +103.7% | 1.77% | +121.8% |
| Q4 2022 | $4,136,453 | -23.1% | 179,924 | -26.2% | 0.80% | -24.5% |
| Q3 2022 | $5,378,000 | -0.4% | 243,674 | -35.3% | 1.06% | -2.6% |
| Q2 2022 | $5,402,000 | +35.4% | 376,678 | +78.5% | 1.09% | +53.7% |
| Q1 2022 | $3,990,000 | -7.3% | 211,024 | -8.7% | 0.71% | +9.3% |
| Q4 2021 | $4,306,000 | -70.4% | 231,024 | -57.3% | 0.65% | -46.4% |
| Q3 2021 | $14,553,000 | +93.4% | 541,022 | +124.7% | 1.21% | +98.7% |
| Q2 2021 | $7,526,000 | – | 240,765 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
| FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
| EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
| Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
| NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
| OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
| Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
| TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |